boston scientific

U.S. Companies Park Profits Overseas, Avoid Taxes

Large American companies are parking more of their profits overseas. A Wall Street Journal analysis found that 60 big companies shielded more than 40 percent of their annual profit from U.S. taxes.

Fortune 500's Top 10 Losers: Down Billions, but Still Huge

Holding a spot on the Fortune 500 list puts a business in august company, but that isn't always synonymous with being successful. Each year, some companies manage to stay on the list despite experiencing profound problems, and losing billions of dollars for their stakeholders.

Earnings, Deals, Hiring: A Busy Day for Big Pharma

Big Pharma didn't rest Thursday, with Celgene, Sanofi-Aventis and AstraZeneca among the big names reporting earnings. A deal between Stryker and Boston Scientific and Sanofi and BMP Sunstone also made the headlines, as did some hiring from Teva. Bristol-Myers Squibb received the anticipated new approval for one of its cancer drugs. But it was Celgene that led drug stocks higher.

FDA Eyes Overhaul of Medical Device Regulation

The Food and Drug Administration is proposing to revamp its regulations of medical devices, the agency said Wednesday. While seeking to improve device safety, the FDA also wants to ease the regulatory environment and foster innovation. But the proposals have the industry concerned.

Legal Briefing: Judge Rejects Guidant Settlement

A few years ago, medical device manufacturer Guidant failed to report problems with some of its heart defibrillators, a failure which led to at least six deaths. The Justice Department's proposed settlement involved a $296 million fine and a plea to a couple of misdemeanors, which a federal judge has deemed too light a punishment.